跳至主要内容
临床试验/EUCTR2011-005330-18-IT
EUCTR2011-005330-18-IT进行中(未招募)不适用

Prospective randomized study to evaluate the efficacy of different protocols IN DRUG PREVENTION OF BRAIN DAMAGE AFTER Carotid angioplasty with stent implantation (CAROTID ARMYDA trial). - ARMYDA_CAROTID

IVERSITA' CAMPUS BIOMEDICO0 个研究点目标入组 150 人开始时间: 2011年12月20日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • symptomatic or asymptomatic patients with reflected economic colordoppler angioTAC and carotid vascular disease of significant (> 70% diameter reduction according to the NASCET criteria or characteristics velocimetric)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • - Patients with recent ischemic stroke and / or presence of acute injury / subacute MRI of the brain.
  • - Patients with active bleeding or with contraindications taking dual antiplatelet therapy
  • - Patients with contraindications to statin therapy for history of severe liver disease, muscle diseases, or otherwise elevated baseline transaminase or CK
  • - Patients with contraindications to MR examination (pacemaker / claustrophobic).

研究者

发起方
IVERSITA' CAMPUS BIOMEDICO

相似试验